CGEM Insider Buying — Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a...

25 insider purchases on record · latest filing 2025-10-30.

Insiders have also filed 192 sale transactions at CGEM.